Navigation Links
Gamma Pharmaceuticals, Inc. Completes Sale and Books Revenue with National Pharmacy Chain
Date:6/27/2011

r Gamma On."  Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market.  A series of innovative marketing programs supports Gamma's product sales and retail partners.

At present Gamma manufactures in North America, and distributes in the United States.  Gamma's products utilize proprietary "Gel Delivery Technology®", to create innovative gel product forms; that give consumers a more pleasant experience.  Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great.  Market categories Gamma targets are growing as rapidly as 60% per year.  Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms and Personal Care Products.  Gamma also develops and manufactures house brands for major retailers.  At this time, Gamma has a total of 36 SKU's and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contact: Gamma Pharmaceuticals, Inc.
Joe Cunningham, CFO (

SOURCE Gamma Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
2. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
3. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
4. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
5. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
6. Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
7. Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimers Disease Announced
8. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
11. U.S. FDA Issues Action Letter for Sugammadex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the UBS Global Healthcare Conference in New ... 22 nd at 11 a.m. Eastern Time. To listen ... please visit the Investor Relations section of the Company,s Web ... for 14 days after the event. About Orexigen® ...
(Date:5/17/2013)... Biotechnology Inc. ("Sony") today announced the launch of the new ... Sony will also be exhibiting its newly rebranded reagent portfolio. ... EC800 flow cytometer, and new SP6800 Spectral Analyzer will be ... held at the San Diego Convention ... May 20 - 22.  The 8-well strip ...
(Date:5/17/2013)... Research explores data on ... also   to   be presented ... the global specialty biopharmaceutical company, announces that it will ... American Psychiatric Association (APA) 166th Annual Meeting in ... being presented represent Shire,s ongoing commitment to the clinical ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... increasingly are applying genomics technologies to toxicology research to ... a variety of organ systems, reports Genetic Engineering ... especially interested in figuring out a new compound,s mechanism ... according to the November 15 issue of GEN ...
... Nov. 18 Arlington Medical Resources (AMR), a,provider of ... finds that over $10 million of CSL Behring,s Privigen ... 2008. Privigen is the newest,brand of intravenous immune globulin ... IVIG is a product created from the blood plasma ...
Cached Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2
(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...
(Date:5/18/2013)... May 18, 2013 Today, Zane ... insurance agents’ role in Marketplaces . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... Human Services (HHS) recently released a much-anticipated statement ...
(Date:5/18/2013)... NY (PRWEB) May 18, 2013 After working ... efforts, SizeItUp formally announced the integration of the ... 2012 Hyundai Genesis is set to stun the automobile market ... style. 2012 Hyundai Genesis is marked as the latest entry ... heads the vehicles lined up for the year 2013. ...
(Date:5/18/2013)... AL (PRWEB) May 18, 2013 Although ... malignant tumors, the association between obesity and esophageal adenocarcinoma, ... for other obesity-related tumors. As reported on ... people are almost twice as likely as those of ... Although the relationship between obesity and esophageal cancer is ...
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... new discovery may lead to more effective screening and treatment ... tumor-like growths and a high risk of developing specific cancers. ... issue of the American Journal of Human Genetics, ... alternate susceptibility gene for Cowden syndrome (CS) and related disorders. ...
... MRIs to skyrocket over the next five ... years, according to Millennium Research Group, WALTHAM, ... US Markets for Women,s Health Imaging Systems 2008 report,the ... magnetic,resonance imaging (MRI) coils, dedicated breast MRI systems, and,breast-specific ...
... of Diabetes Educators (AADE) today announced results from ... between people with diabetes that require insulin injections ... results, 33 percent of respondents have experienced some ... percent strongly agreed/25 percent somewhat agreed), 14 percent ...
... Research Laboratories,Inc. (CRL) announced today that it has ... follow-up libraries. Such ultra-fast,hit-to-lead libraries are now produced ... three to six days which enables critical acceleration ... new industry benchmark.,This state-of-the-art high-throughput chemistry technology was ...
... Benefit Services, Inc., today announced the release of their 2008 Benefit ... trends and strategies. , ... Syosset, NY (PRWEB) August ... Inc., today announced the release of their 2008 Benefit Plan Report, ...
... The CDC,s revised statistics regarding new HIV infections emphasizes the critical ... Startling statistics show 25% of persons infected don,t know they carry ... ... New cases of HIV infection in the U.S. have been underestimated ...
Cached Medicine News:Health News:Beyond PTEN: Alternate genes linked to breast, thyroid and kidney cancer predisposition 2Health News:Adjunct Breast Imaging Market to Increase by Almost 28% per Year Through 2013 2Health News:New survey explores the impact of insulin injections on people with diabetes 2Health News:New survey explores the impact of insulin injections on people with diabetes 3Health News:New survey explores the impact of insulin injections on people with diabetes 4Health News:ChemBridge Research Laboratories, Inc. (CRL) has Established an Industry Record and Benchmark in Hit-to-Lead Libraries Turn-around Time 2Health News:Average Annual Medical Premium Costs Increased 6%, Says 2008 Benefit Plan Report from C&B Consulting 2Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 2Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 3
Classic Trial Frames UB3 that has long set the standard....
... This quality Universal Trial Frame comes at a very attractive ... Temple angle, Temple length 4 1/8" to 5 1/2" ... angle 0 to 30, PD adjustable 24 to 40mm ... Axial calibration on each lens: left - 120 to 0 ...
Sickle blade. Flat stock myringotomy blade....
... offer the superior cutting advantages of ... the exclusive Rib-Back design for greater ... producer offer the wide selection of ... Every blade is packaged in a ...
Medicine Products: